365体育亚洲唯一官网入口 - 首页|欢迎您
Hello! Welcome to the official website of Betta Pharmaceuticals!
Service Hotline：+86-571-86130357
Add to Favorites
|
Online Feedback
中文
Home
|
About
|
Product
|
New Drug
|
Dream Works
|
Investor
|
Talent
|
Contact
Adhering to an innovative development philosophy to benefit the people, Betta Pharmaceuticals commits to the new drug development to achieve scientific innovation for the people, create more affordable medicines, and make people live better.
· Company Profile
· Management Team
· Awards & Recognition
· Culture
· Icotinib
· Ensartinib
· Bevacizumab
· R&D
· Pipeline
· Partner
· Park
·Core Strengths
· IR Contact
· Recruitment
· Campus
· Contact
Product / Ensartinib
Product Introduction
Mechanism Of Action
Scientific Research
Home
>
Product
>
Ensartinib
Related literature
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
Copyright © 2019 All Rights Reserved Betta Pharmaceuticals Co., Ltd.
浙ICP备11052940号-2
Site Map
|
Copyright
|
Feedback
|
Enterprise E-Mail
|
OA Login
